Agenus Inc., a clinical-stage biotechnology firm, discovers and develops therapies to activate the body's immune program towards most cancers and bacterial infections in The us and internationally. It provides Retrocyte Exhibit, an antibody expression System with the identification of entirely human and humanized monoclonal antibodies; and Display